222 related articles for article (PubMed ID: 31276728)
21. Loss of Protection by Antiepileptic Drugs in Lipopolysaccharide-primed Pilocarpine-induced Status Epilepticus is Mediated via Inflammatory Signalling.
Vyas P; Tulsawani RK; Vohora D
Neuroscience; 2020 Aug; 442():1-16. PubMed ID: 32592825
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and tolerability of anti-epileptic drugs-an internet study.
Wieshmann UC; Baker G
Acta Neurol Scand; 2017 May; 135(5):533-539. PubMed ID: 27757951
[TBL] [Abstract][Full Text] [Related]
23. Carbamazepine versus levetiracetam in epilepsy due to neurocysticercosis.
Santhosh AP; Kumar Goyal M; Modi M; Kharbanda PS; Ahuja CK; Tandyala N; Prabhat N; Singh R; Mehta S; Vinay Mahesh K
Acta Neurol Scand; 2021 Mar; 143(3):242-247. PubMed ID: 33006755
[TBL] [Abstract][Full Text] [Related]
24. A comparison of four antiepileptic drugs in status epilepticus: experience from India.
Misra UK; Kalita J
Int J Neurosci; 2016 Nov; 126(11):1013-9. PubMed ID: 26456955
[TBL] [Abstract][Full Text] [Related]
25. Anticonvulsant effects of levetiracetam and levetiracetam-diazepam combinations in experimental status epilepticus.
Mazarati AM; Baldwin R; Klitgaard H; Matagne A; Wasterlain CG
Epilepsy Res; 2004 Feb; 58(2-3):167-74. PubMed ID: 15120747
[TBL] [Abstract][Full Text] [Related]
26. Anti‑tumor effects of anti‑epileptic drugs in malignant glioma cells.
Yagi C; Tatsuoka J; Sano E; Hanashima Y; Ozawa Y; Yoshimura S; Yamamuro S; Sumi K; Hara H; Katayama Y; Yoshino A
Oncol Rep; 2022 Dec; 48(6):. PubMed ID: 36281939
[TBL] [Abstract][Full Text] [Related]
27. Effects of carbamazepine, eslicarbazepine, valproic acid and levetiracetam on bone microarchitecture in rats.
Diemar SS; Sejling AS; Eiken P; Ellegaard M; Ding M; Andersen NB; Jørgensen NR
Pharmacol Rep; 2020 Oct; 72(5):1323-1333. PubMed ID: 32193854
[TBL] [Abstract][Full Text] [Related]
28. Comparing the efficacy of sodium valproate and levetiracetam following initial lorazepam in elderly patients with generalized convulsive status epilepticus (GCSE): A prospective randomized controlled pilot study.
Nene D; Mundlamuri RC; Satishchandra P; Prathyusha PV; Nagappa M; Bindu PS; Raghavendra K; Saini J; Bharath RD; Thennarasu K; Taly AB; Sinha S
Seizure; 2019 Feb; 65():111-117. PubMed ID: 30682680
[TBL] [Abstract][Full Text] [Related]
29. Anticonvulsant and neuroprotective effects of carbamazepine-levetiracetam adjunctive treatment in convulsive status epilepticus rat model: Inhibition of cholinergic transmission.
Osuntokun OS; Abdulwahab UF; Akanji NO; Adedokun KI; Adekomi AD; Olayiwola G
Neurosci Lett; 2021 Sep; 762():136167. PubMed ID: 34389480
[TBL] [Abstract][Full Text] [Related]
30. Prophylactic treatment with levetiracetam after status epilepticus: lack of effect on epileptogenesis, neuronal damage, and behavioral alterations in rats.
Brandt C; Glien M; Gastens AM; Fedrowitz M; Bethmann K; Volk HA; Potschka H; Löscher W
Neuropharmacology; 2007 Aug; 53(2):207-21. PubMed ID: 17585956
[TBL] [Abstract][Full Text] [Related]
31. Effects of valproate, carbamazepine, and levetiracetam on the antioxidant and oxidant systems in epileptic patients and their clinical importance.
Varoglu AO; Yildirim A; Aygul R; Gundogdu OL; Sahin YN
Clin Neuropharmacol; 2010 May; 33(3):155-7. PubMed ID: 20502135
[TBL] [Abstract][Full Text] [Related]
32. Prevention of status epilepticus-induced brain edema and neuronal cell loss by repeated treatment with high-dose levetiracetam.
Itoh K; Inamine M; Oshima W; Kotani M; Chiba Y; Ueno M; Ishihara Y
Brain Res; 2015 May; 1608():225-34. PubMed ID: 25770058
[TBL] [Abstract][Full Text] [Related]
33. The impairment of motor coordination following chronic carbamazepine-levetiracetam combination treatment with evidence of corticocerebellar toxicity in male Wistar rats.
Samson Osuntokun O; Grace Akingboye B; Olayiwola G; Adekemi Abayomi T; Oladele Ayoka A
Brain Res; 2021 Sep; 1767():147565. PubMed ID: 34175264
[TBL] [Abstract][Full Text] [Related]
34. Evaluating an etiologically relevant platform for therapy development for temporal lobe epilepsy: effects of carbamazepine and valproic acid on acute seizures and chronic behavioral comorbidities in the Theiler's murine encephalomyelitis virus mouse model.
Barker-Haliski ML; Dahle EJ; Heck TD; Pruess TH; Vanegas F; Wilcox KS; White HS
J Pharmacol Exp Ther; 2015 May; 353(2):318-29. PubMed ID: 25755209
[TBL] [Abstract][Full Text] [Related]
35. Characterization and treatment of spontaneous recurrent seizures following nerve agent-induced status epilepticus in mice.
McCarren HS; Eisen MR; Nguyen DL; Dubée PB; Ardinger CE; Dunn EN; Haines KM; Santoro AN; Bodner PM; Ondeck CA; Honnold CL; McDonough JH; Beske PH; McNutt PM
Epilepsy Res; 2020 May; 162():106320. PubMed ID: 32182542
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic window of opportunity for the neuroprotective effect of valproate versus the competitive AMPA receptor antagonist NS1209 following status epilepticus in rats.
Langer M; Brandt C; Zellinger C; Löscher W
Neuropharmacology; 2011; 61(5-6):1033-47. PubMed ID: 21736883
[TBL] [Abstract][Full Text] [Related]
37. Differential effects of antiepileptic drugs on steroidogenesis in a human in vitro cell model.
Gustavsen MW; von Krogh K; Taubøll E; Zimmer KE; Dahl E; Olsaker I; Ropstad E; Verhaegen S
Acta Neurol Scand Suppl; 2009; (189):14-21. PubMed ID: 19566492
[TBL] [Abstract][Full Text] [Related]
38. Preliminary evidence about irritability in patients with epilepsy treated by perampanel as first add-on therapy compared to levetiracetam and valproic acid.
Liguori C; Turner K; Izzi F; Assogna M; Canevini MP; Mercuri NB; Placidi F
CNS Neurosci Ther; 2019 May; 25(5):632-637. PubMed ID: 30675751
[TBL] [Abstract][Full Text] [Related]
39. Comparison of reproductive effects of levetiracetam and valproate studied in prepubertal porcine ovarian follicular cells.
Taubøll E; Gregoraszczuk EL; Tworzydø A; Wójtowicz AK; Ropstad E
Epilepsia; 2006 Sep; 47(9):1580-3. PubMed ID: 16981877
[TBL] [Abstract][Full Text] [Related]
40. Effects of valproate, lamotrigine, and levetiracetam monotherapy on bone health in newly diagnosed adult patients with epilepsy.
Guo Y; Lin Z; Huang Y; Yu L
Epilepsy Behav; 2020 Dec; 113():107489. PubMed ID: 33220583
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
